Patents by Inventor Michael L. Jones

Michael L. Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12074850
    Abstract: A first risk analysis of a message is performed. In the event the first risk analysis results in a determination that the message meets a first criteria, at least a portion of the message is modified prior to sending a modified version of the message to a specified recipient of the message, and a second risk analysis of the message is performed. The first risk analysis is performed before sending the modified version of the message and the modified version of the message is sent to the specified recipient of the message prior to a conclusion of the second risk analysis. In the event the second risk analysis results in a determination that the message meets a second criteria, content of the message that was previously prevented from being accessed by the specified recipient is provided to the specified recipient of the message.
    Type: Grant
    Filed: July 28, 2020
    Date of Patent: August 27, 2024
    Assignee: AGARI DATA, INC.
    Inventors: Bjorn Markus Jakobsson, Theodore C. Loder, Jacob R. Rideout, Arthur Kwan Jakobsson, Michael L. Jones
  • Publication number: 20240197365
    Abstract: An endoluminal needle or punch is describes wherein the distal end of the endoluminal needle is able to articulate laterally out of the longitudinal axis of the steerable endoluminal needle. The endoluminal needle further comprise a blunted distal end configuration that is minimally traumatic. Under control by the user, at the proximal end of the endoluminal needle, a sharp stylet can be advanced to punch tissue and then be retracted to maximize safety. The endoluminal needle is configured for use within an introducer.
    Type: Application
    Filed: December 18, 2023
    Publication date: June 20, 2024
    Applicant: Indian Wells Medical, Inc.
    Inventors: Jay A. Lenker, Michael L. Jones, James A. Carroll
  • Publication number: 20240008898
    Abstract: An endoluminal needle or punch is describes wherein the distal end of the endoluminal needle is able to articulate laterally out of the longitudinal axis of the steerable endoluminal needle. The endoluminal needle further comprise a blunted distal end configuration that is minimally traumatic. Under control by the user, at the proximal end of the endoluminal needle, a sharp stylet can be advanced to punch tissue and then be retracted to maximize safety. The endoluminal needle is configured for use within an introducer.
    Type: Application
    Filed: September 22, 2023
    Publication date: January 11, 2024
    Applicant: Indian Wells Medical, Inc.
    Inventors: Jay A. Lenker, Michael L. Jones, James A. Carroll
  • Patent number: 11844548
    Abstract: An endoluminal needle or punch is describes wherein the distal end of the endoluminal needle is able to articulate laterally out of the longitudinal axis of the steerable endoluminal needle. The endoluminal needle further comprise a blunted distal end configuration that is minimally traumatic. Under control by the user, at the proximal end of the endoluminal needle, a sharp stylet can be advanced to punch tissue and then be retracted to maximize safety. The endoluminal needle is configured for use within an introducer.
    Type: Grant
    Filed: September 22, 2023
    Date of Patent: December 19, 2023
    Assignee: Indian Wells Medical, Inc.
    Inventors: Jay A. Lenker, Michael L. Jones, James A. Carroll
  • Patent number: 11833275
    Abstract: A method for forming a porous implant suitable for a cavity from which tissue has been removed includes incorporating a gas or a pore forming agent into an alginate solution; transferring the alginate solution with the gas or the pore forming agent into a solidified body mold having a desired shape with an outer surface; removing the water from the solidified body; and subjecting the solidified body to a conversion solution to convert the outer surface to a less soluble alginate creating a composition comprising the outer surface having less soluble alginate and a core having more soluble alginate.
    Type: Grant
    Filed: September 1, 2020
    Date of Patent: December 5, 2023
    Assignee: SenoRx, Inc.
    Inventors: Amit Govil, Michael L. Jones, Paul Lubock
  • Patent number: 11771463
    Abstract: An endoluminal needle or punch is describes wherein the distal end of the endoluminal needle is able to articulate laterally out of the longitudinal axis of the steerable endoluminal needle. The endoluminal needle further comprise a blunted distal end configuration that is minimally traumatic. Under control by the user, at the proximal end of the endoluminal needle, a sharp stylet can be advanced to punch tissue and then be retracted to maximize safety. The endoluminal needle is configured for use within an introducer.
    Type: Grant
    Filed: September 22, 2020
    Date of Patent: October 3, 2023
    Inventors: Jay A. Lenker, Michael L. Jones, James A. Carroll
  • Publication number: 20230208813
    Abstract: At least one of a measure of trust or a measure of spoofing risk associated with a sender of a message is determined. A measure of similarity between an identifier of the sender of the message and an identifier of at least one trusted contact of a recipient of the message is determined. The measure of similarity is combined with at least one of the measure of trust or the measure of spoofing risk to at least in part determine a combined measure of risk associated with the message. Based at least in part on the combined measure of risk associated with the message, a verification action is performed including by automatically providing an inquiry message that requests a response to be provided.
    Type: Application
    Filed: February 27, 2023
    Publication date: June 29, 2023
    Inventors: Bjorn Markus Jakobsson, Theodore C. Loder, Jacob R. Rideout, Arthur Kwan Jakobsson, Michael L. Jones
  • Patent number: 11595354
    Abstract: At least one of a measure of trust or a measure of spoofing risk associated with a sender of a message is determined. A measure of similarity between an identifier of the sender of the message and an identifier of at least one trusted contact of a recipient of the message is determined. The measure of similarity is combined with at least one of the measure of trust or the measure of spoofing risk to at least in part determine a combined measure of risk associated with the message. Based at least in part on the combined measure of risk associated with the message, a verification action is performed including by automatically providing an inquiry message that requests a response to be provided.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: February 28, 2023
    Assignee: Agari Data, Inc.
    Inventors: Bjorn Markus Jakobsson, Theodore C. Loder, Jacob R. Rideout, Arthur Kwan Jakobsson, Michael L. Jones
  • Patent number: 11354635
    Abstract: Systems and methods for providing a payment messaging interface may include receiving, at a computing device comprising a processor, transaction information regarding the transaction. Once the transaction information is received, the transaction information may be translated into a data structure that corresponds to a payment processor. Once the transaction information has been translated, the data structure may be transmitted to the payment processor.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: June 7, 2022
    Assignee: NCR Corporation
    Inventors: Michael L. Jones, Carl L. Best
  • Publication number: 20210211411
    Abstract: At least one of a measure of trust or a measure of spoofing risk associated with a sender of a message is determined. A measure of similarity between an identifier of the sender of the message and an identifier of at least one trusted contact of a recipient of the message is determined. The measure of similarity is combined with at least one of the measure of trust or the measure of spoofing risk to at least in part determine a combined measure of risk associated with the message. Based at least in part on the combined measure of risk associated with the message, a verification action is performed including by automatically providing an inquiry message that requests a response to be provided.
    Type: Application
    Filed: March 19, 2021
    Publication date: July 8, 2021
    Inventors: Bjorn Markus Jakobsson, Theodore C. Loder, Jacob R. Rideout, Arthur Kwan Jakobsson, Michael L. Jones
  • Patent number: 10992645
    Abstract: At least one of a measure of trust or a measure of spoofing risk associated with a sender of a message is determined. A measure of similarity between an identifier of the sender of the message and an identifier of at least one trusted contact of a recipient of the message is determined. The measure of similarity is combined with at least one of the measure of trust or the measure of spoofing risk to at least in part determine a combined measure of risk associated with the message. The sender of the message is not included in the at least one trusted contact of the recipient of the message. Based at least in part on the combined measure of risk associated with the message, the message is modified to alter content of a data field that includes an identification of the sender of the message.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: April 27, 2021
    Assignee: Agari Data, Inc.
    Inventors: Bjorn Markus Jakobsson, Theodore C. Loder, Jacob R. Rideout, Arthur Kwan Jakobsson, Michael L. Jones
  • Publication number: 20210105252
    Abstract: A first risk analysis of a message is performed. In the event the first risk analysis results in a determination that the message meets a first criteria, at least a portion of the message is modified prior to sending a modified version of the message to a specified recipient of the message, and a second risk analysis of the message is performed. The first risk analysis is performed before sending the modified version of the message and the modified version of the message is sent to the specified recipient of the message prior to a conclusion of the second risk analysis. In the event the second risk analysis results in a determination that the message meets a second criteria, content of the message that was previously prevented from being accessed by the specified recipient is provided to the specified recipient of the message.
    Type: Application
    Filed: July 28, 2020
    Publication date: April 8, 2021
    Inventors: Bjorn Markus Jakobsson, Theodore C. Loder, Jacob R. Rideout, Arthur Kwan Jakobsson, Michael L. Jones
  • Publication number: 20210023278
    Abstract: A method for forming a porous implant suitable for a cavity from which tissue has been removed includes incorporating a gas or a pore forming agent into an alginate solution; transferring the alginate solution with the gas or the pore forming agent into a solidified body mold having a desired shape with an outer surface; removing the water from the solidified body; and subjecting the solidified body to a conversion solution to convert the outer surface to a less soluble alginate creating a composition comprising the outer surface having less soluble alginate and a core having more soluble alginate.
    Type: Application
    Filed: September 1, 2020
    Publication date: January 28, 2021
    Inventors: Amit Govil, Michael L. Jones, Paul Lubock
  • Publication number: 20210000505
    Abstract: An endoluminal needle or punch is describes wherein the distal end of the endoluminal needle is able to articulate laterally out of the longitudinal axis of the steerable endoluminal needle. The endoluminal needle further comprise a blunted distal end configuration that is minimally traumatic. Under control by the user, at the proximal end of the endoluminal needle, a sharp stylet can be advanced to punch tissue and then be retracted to maximize safety. The endoluminal needle is configured for use within an introducer.
    Type: Application
    Filed: September 22, 2020
    Publication date: January 7, 2021
    Applicant: Indian Wells Medical, Inc.
    Inventors: Jay A. Lenker, Michael L. Jones, James A. Carroll
  • Patent number: 10805270
    Abstract: A first risk analysis of a message is performed. In the event the first risk analysis results in a determination that the message meets a first criteria, at least a portion of the message is modified prior to sending a modified version of the message to a specified recipient of the message, and a second risk analysis of the message is performed. The first risk analysis is performed before sending the modified version of the message and the modified version of the message is sent to the specified recipient of the message prior to a conclusion of the second risk analysis. In the event the second risk analysis results in a determination that the message meets a second criteria, content of the message that was previously prevented from being accessed by the specified recipient is provided to the specified recipient of the message.
    Type: Grant
    Filed: March 8, 2017
    Date of Patent: October 13, 2020
    Assignee: Agari Data, Inc.
    Inventors: Bjorn Markus Jakobsson, Theodore C. Loder, Jacob R. Rideout, Arthur Kwan Jakobsson, Michael L. Jones
  • Patent number: 10786604
    Abstract: In one form, the invention is directed to a method for forming a porous implant suitable for a cavity from which tissue has been removed, including mixing soluble alginate and a radiopaque imaging agent with water; incorporating a gas or a pore forming agent into the alginate-water mixture; transferring the alginate-water mixture with the gas or the pore forming agent into a mold to form the mixture into a solid body of desired shape; removing the water from the body; and converting at least part of the soluble alginate to a less soluble alginate. In another form, the invention includes forming a mixture by mixing about 0.5 percent to about 4 percent by weight chitosan into an acidified aqueous solution containing 1 percent to 25 percent by weight acetic acid, along with about 0.5 percent to about 5 percent by weight of a powdered radiopaque imaging agent.
    Type: Grant
    Filed: May 7, 2014
    Date of Patent: September 29, 2020
    Assignee: SenoRx, Inc.
    Inventors: Amit Govil, Michael L. Jones, Paul Lubock
  • Patent number: 10779858
    Abstract: An endoluminal needle or punch is describes wherein the distal end of the endoluminal needle is able to articulate laterally out of the longitudinal axis of the steerable endoluminal needle. The endoluminal needle further comprise a blunted distal end configuration that is minimally traumatic. Under control by the user, at the proximal end of the endoluminal needle, a sharp stylet can be advanced to punch tissue and then be retracted to maximize safety. The endoluminal needle is configured for use within an introducer.
    Type: Grant
    Filed: June 7, 2018
    Date of Patent: September 22, 2020
    Assignee: Indian Wells Medical, Inc.
    Inventors: Jay A. Lenker, Michael L. Jones, James A. Carroll
  • Patent number: 10413750
    Abstract: The disclosure describes devices and methods for asymmetrical irradiation at a body cavity or site, such as after removal of tissue, e.g. biopsy or cancer. One device includes a lumen which is off-set or off-settable from a longitudinal axis to increase the intensity of radiation received from a radiation source by a first tissue portion surrounding the body cavity and to reduce or minimize radiation received by a second tissue portion (e.g. healthy tissue) surrounding the body cavity.
    Type: Grant
    Filed: August 12, 2016
    Date of Patent: September 17, 2019
    Assignee: HOLOGIC, INC.
    Inventors: Paul Lubock, Michael L. Jones, Frank R. Louw
  • Publication number: 20190266591
    Abstract: Systems and methods for activating a remote device may include receiving, at a computing device, an authorization request regarding the transaction. The authorization request may be received from a user mobile device. Once the authorization request is received, the translation information may be translated into a data structure that corresponds to a payment processor. The data structure may be transmitted to the payment processor. An authorization message may be transmitted to a point-of sale device.
    Type: Application
    Filed: February 27, 2018
    Publication date: August 29, 2019
    Inventor: Michael L. Jones
  • Publication number: 20190260713
    Abstract: At least one of a measure of trust or a measure of spoofing risk associated with a sender of a message is determined. A measure of similarity between an identifier of the sender of the message and an identifier of at least one trusted contact of a recipient of the message is determined. The measure of similarity is combined with at least one of the measure of trust or the measure of spoofing risk to at least in part determine a combined measure of risk associated with the message. The sender of the message is not included in the at least one trusted contact of the recipient of the message. Based at least in part on the combined measure of risk associated with the message, the message is modified to alter content of a data field that includes an identification of the sender of the message.
    Type: Application
    Filed: April 30, 2019
    Publication date: August 22, 2019
    Inventors: Bjorn Markus Jakobsson, Theodore C. Loder, Jacob R. Rideout, Arthur Kwan Jakobsson, Michael L. Jones